Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDeferred TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Change in Cash (2019 - 2026)

Sanofi's Change in Cash history spans 6 years, with the latest figure at -$2.5 billion for Q1 2026.

  • On a quarterly basis, Change in Cash fell 527.59% to -$2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.1 billion, a 9.04% decrease, with the full-year FY2025 number at $251.4 million, up 118.54% from a year prior.
  • Change in Cash hit -$2.5 billion in Q1 2026 for Sanofi, up from -$10.7 billion in the prior quarter.
  • Over the last five years, Change in Cash for SNY hit a ceiling of $8.3 billion in Q2 2025 and a floor of -$10.7 billion in Q4 2025.
  • Historically, Change in Cash has averaged -$740.9 million across 3 years, with a median of -$422.2 million in 2024.
  • The widest YoY moves for Change in Cash: up 424.59% in 2025, down 686.9% in 2025.
  • Tracing SNY's Change in Cash over 3 years: stood at -$1.4 billion in 2024, then tumbled by 686.9% to -$10.7 billion in 2025, then soared by 76.82% to -$2.5 billion in 2026.
  • Business Quant data shows Change in Cash for SNY at -$2.5 billion in Q1 2026, -$10.7 billion in Q4 2025, and $1.7 billion in Q3 2025.